SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 262 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $420 | +10.2% | 10 | 0.0% | 0.00% | – |
Q4 2022 | $381 | – | 10 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 10 | -16.7% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 12 | -94.1% | 0.00% | – |
Q4 2021 | $8,000 | – | 204 | +1940.0% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 10 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 10 | -80.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 50 | +316.7% | 0.00% | – |
Q2 2019 | $2,000 | -50.0% | 12 | -53.8% | 0.00% | – |
Q1 2019 | $4,000 | +100.0% | 26 | +44.4% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 18 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | 0.0% | 18 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | 0.0% | 18 | -47.1% | 0.00% | – |
Q2 2017 | $3,000 | +200.0% | 34 | +21.4% | 0.00% | – |
Q4 2016 | $1,000 | -50.0% | 28 | -56.2% | 0.00% | – |
Q2 2016 | $2,000 | – | 64 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |